Use of alkaline phosphatase in the treatment of reduced renal function
US8586032B2 · kind B2 · utility
9Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2008 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Feb 10, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/03001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the field of medicine and in particular to the use of alkaline phosphatase in the treatment of renal diseases, such as reduced renal function. The present invention also relates to the field of pharmacy and in particular to the pharmaceutical use of alkaline phosphatase. The present invention provides an alternative treatment to improve a situation in which the renal function is reduced by using alkaline phosphatase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.